Highlights
A collection of news and information related to Novartis AG published by this site and its partners.
Displaying items 1-12 of 102
» View ky3.com items only
1
2
3
4
5
6
7
8
9
•
Next >
-
Valeant near deal to acquire Bausch & Lomb: source
ReutersNEW YORK (Reuters) - Canada's Valeant Pharmaceuticals International is nearing a deal to acquire eye care company Bausch & Lomb Holdings Inc from Warburg Pincus LLC for about $9 billion, a person familiar with the matter said on Friday. Valeant shares...Tags: U.S. Department of Justice, Drugs and Medicines, Prescription Drugs, Pharmaceuticals, Valeant Pharmaceuticals International
-
RPT-FEATURE-Pfizer takes its shot at a vaccine for evasive superbug
ReutersBy Julie Steenhuysen CHICAGO, May 23 (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year...Tags: Penicillin (drug), Hospitals and Clinics, Merck & Company Incorporated, AIDS, Wyeth
-
Immune system cancer drugs tipped to be a $35 bln market
Reuters* Potential sales of $35 bln a year over next 10 years - Citigroup * Immunotherapy may be used in up to 60 percent of cancers * Bristol-Myers Squibb and Roche both upgraded to "buy" By Ben Hirschler LONDON, May 22 (Reuters) - A new wave of medicines...Tags: Drugs and Medicines, Food and Drug Administration, Merck & Company Incorporated, Weather Reports, Amgen Inc.
-
Immune system cancer drugs tipped to be a $35 billion market
ReutersLONDON (Reuters) - A new wave of medicines that tap the power of the immune system to fight cancer could become the biggest drug class in history, with potential sales of $35 billion a year. That bullish sales forecast by analysts at U.S. bank...Tags: Drugs and Medicines, Merck & Company Incorporated, Food and Drug Administration, Weather Reports, Roche Holding AG
-
Inmunoterapia contra el cáncer podría ser un mercado de 35.000 mln dlrs anuales
ReutersPor Ben Hirschler LONDRES, 22 may (Reuters) - Una nueva ola de medicinas que emplea el poder del sistema inmunológico para luchar contra el cáncer podría convertirse en el mayor grupo de medicamentos de la historia, con ventas potenciales de 35.000...Tags: Bristol Myers Squibb Company, Merck & Company Incorporated, Amgen Inc., Roche Holding AG, AstraZeneca Plc
-
Tour of California: Van Garderen retains overall lead
San Jose Mercury NewsTejay van Garderen left no doubt Friday that he is America's next big cycling star. The slender Montanan struck decisively on a 19.6-mile individual time trial designed by descendants of the Marquis de Sade and in the process all but won the Amgen...Tags: Lance Armstrong, Cameron Meyer, Gaming, Garmin Ltd., Trials
-
Deals of the day -- mergers and acquisitions
ReutersMay 16 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday: ** DDR Corp, owner of shopping centers where big-box retailers are located, said on Wednesday it had agreed to buy from Blackstone Group LP...Tags: European Union, Drugs and Medicines, Companies and Corporations, Germany, Swiss Confederation
-
Novartis says has no intention of buying Actavis
ReutersZURICH, May 16 (Reuters) - Novartis has no plans to bid for U.S.-based generic drugmaker Actavis, which is the subject of intense takeover speculation, a spokesman for the Swiss drugmaker said on Thursday. "We have no intention to pursue them," spokesman...Tags: The Wall Street Journal
-
DEALTALK-Novartis' Vasella exit opens door to Roche stake sale
Reuters* Novartis' one-third stake in Roche built up under Vasella * Vasella exit, retirement of Roche chairman could thaw relations * Roche seen as most likely buyer for the stake * Could make offer in second half of this year - analyst By Caroline...Tags: Genentech Inc., Drugs and Medicines, Merck & Company Incorporated, Swiss Confederation, Earnings
-
Acciones europeas alcanzan máximo 5 años impulsadas por papeles suizos
ReutersPor Sudip Kar-Gupta LONDRES, 15 mayo (Reuters) - Las acciones europeas treparon el miércoles a nuevos máximos de cinco años, lideradas por los avances de papeles suizos tras un retroceso del franco suizo que debería continuar beneficiando a los... -
SEC says new settlements end 'Golden Goose' insider trading case
Reuters* Jamil Bouchareb, Daniel Corbin settle civil cases * Tips said to be misappropriated from PR firm executive May 15 (Reuters) - The U.S. Securities and Exchange Commission on Wednesday said it has reached settlements with the last two defendants in an...Tags: Punishment, Prisons, Anheuser-Busch InBev, Lehman Brothers Holdings Inc., Trials
-
Swiss stocks push European shares to fresh peaks
ReutersLONDON, May 15 (Reuters) - European shares scaled fresh five-year highs on Wednesday, led by gains for several major Swiss stocks after a currency shift that should continue to buoy the country's exporters. The pan-European FTSEurofirst 300 index...Tags: Credit Ratings, Central Bank, Exports
May 24, 2013
|Story| Reuters
May 23, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 18, 2013
|Story| McClatchy-Tribune
May 16, 2013
|Story| Reuters
May 16, 2013
|Story| Reuters
May 16, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
Original site for Novartis AG topic gallery.